Study finds RSV may evade vaccines via rapid mutation

For most people, respiratory syncytial virus (RSV) is about as dangerous as the common cold. But for children younger than 6 months old, and for people whose immune defenses have been weakened by age, disease, chemotherapy or transplantation, RSV can be fatal.